SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers - Jones, GG; del, Rio IB; Sari, S; Sekerim, A; Young, LC; Hartig, N; Zubiaur, IA; El-Bahrawy, MA; Hynds, RE; Lei, W; Molina-Arcas, M; Downward, J; et al. (Nature Communications, 2019)